European Organisation for Research and Treatment of Cancer
Acronym: EORTC
General Information
Identification Code: 70539554035-46
Website: http://www.eortc.org
Entity Form: AISBL
Registration Category: Non-governmental organisations, platforms and networks and similar
Registration Date: 8/20/2010
Last Update: 5/2/2024
Mission & Interests
Goals: The European Organisation for Research and Treatment of Cancer (EORTC) has delivered investigator driven, changing practice clinical trials since 1962. Its mission is to improve survival and quality of life of cancer patients. The EORTC is a not-for-profit independent organisation performing multidisciplinary clinical research activities across tumor types. The EORTC aims to improve the standard of cancer treatment through the testing of more effective therapeutic strategies based on drugs, surgery and/or radiotherapy that are already in use. EORTC’s activities involve on a voluntary basis more than 3000 medical doctors and scientists from some 800 university hospitals in 35 countries. EORTC clinical trials are involving several thousands of cancer patients on a yearly basis. The EORTC operates on an independent basis, and in this capacity is able to work in partnership with the pharmaceutical industry in evaluating innovative molecules.
Interests Represented: Does not represent commercial interests
Interests:
- Public health
- Research and innovation
Levels of Interest:
- european
- global
Activities
Main EU Legislative Proposals: - Regulation on clinical trials on medicinal products for human use.
- Regulation on Health Technology Assessment.
- Early access to medicines: PRIME, accelerated assessment, conditional market authorization.
- Good Clinical Practice implementation.
- General Data Protection Regulation.
- Regulation of the European Parliament and of the Council on in vitro diagnostic medical devices.
- Medical Device Regulation
- Euratom and radioprotection.
- EU Beating Cancer plan.
- EU Cancer Mission.
- EU Roadmap for a pharmaceutical strategy for Europe.
- Pharmaceutical strategy for Europe
- EU pharmaceutical legislation
- EU Partnership for Health Innovation.
- European Health Data Space
Communication Activities: Participation in workshops and conference involving EU institutions officials. Position statement in collaboration with stakeholders groups such European Cancer Organisation, European Alliance for Personalised Medicine, BioMedAlliance, Rare Cancers Europe, EFGCP, European Data in Health Research Alliance, European Federation of Pharmaceutical Industries, FIPRA.
EORTC is represented in the following working groups: Commission Expert Group on Clinical Trials, Commission HTA stakeholders pool, EMA CTIS new delivery model, EMA EV- Expert Working Group, Accelerating clinical trials in the EU (ACT EU) initiative, .
The EORTC is co-chairing the Cancer Medicines Forum together with the European Medicines Agency (EMA) which aims to advance treatment optimisation for approved cancer medicines. This includes by identifying and prioritizing research questions as well as policy issues emerging from the academic community
Inter-institutional or Unofficial Groupings: Cancer
Head Office
Address: avenue Mounier, 83
Post Code: 1200
City: Brussels
Country: BELGIUM
Phone:
Indic Phone: 32
Phone Number: 27741611
EU Office
Address: avenue Mounier, 83
Post Code: 1200
City: Brussels
Country: BELGIUM
Phone:
Indic Phone: 32
Phone Number: 27741611
Financial Data
Closed Year:
Start Date:
End Date:
Funding Sources:
- Grants
- Other
- Public funding
Other Source Info: EORTC raised 38.6 million euros incomes in 2022. 47% is coming from grants from the industry, 12% is coming from grants from non-commercial partners,
26% from from clinical research expert services and license for Quality of Life research tools, 7% from translation of Quality of Life questionnaires, 6% from subsidies, 2% from congresses/events
Contributions:
- Amount: 0Currency: €_id:Buffer:0: 1041: 642: 613: 1184: 1585: 2126: 1827: 328: 869: 9010: 6811: 209
- Amount: 0Currency: €_id:Buffer:0: 1041: 642: 613: 1184: 1585: 2126: 1827: 328: 869: 9010: 6811: 210
Total Budget: 57000
Grants:
Current Year:
Grants:
Membership Information
Members10 Percent: 2
Members25 Percent: 1
Members: 3
Members F T E: 0.44999998807907104
Info Members: We are collaborating with VLASSEMBROUCK Consult/ABV Development for our interest representation activities (64547 euros in 2023)
Structure
Structure Type: Structure
Is Member Of: Our members are medical doctors and/or scientists affiliated to some 800 university hospitals that are participating to EORTC clinical and translational research activities.
https://www.eortc.org/members/
Organisation Members: European Cancer Organisation
European Forum for Good Clinical Practice
European Alliance for Personnalised Medicine
European Association for NeuroOncology
European Association of Urology
European School of Oncology
European Association of Urology
American Association for Cancer Research
European Society for Therapeutic Radiology and Oncology
European Society for Medical Oncology
American Society for Therapeutic Radiology and Oncology
International Society of Geriatric Oncology
International Society of Pediatric Oncology
International Union Against Cancer
International Network for Cancer Research and Treatment
Organisation of European Cancer Institutes
European Oncology Nursing Society
European Society of Pathology
European Society of Radiology
Current Job Opportunities
Policy Advisor for Cancer Research Initiatives
European Organisation for Research and Treatment of Cancer
mid-levelBrussels, BelgiumFull-time-time
Posted: 9/23/2025
Events and Communications Assistant
European Organisation for Research and Treatment of Cancer
juniorBrussels, Belgiumfull-time-time
Posted: 9/3/2025